Trial Profile
Adipose-Derived Stem Cells (ADSCs) Injections for Liver Cirrhosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Apr 2018
Price :
$35
*
At a glance
- Drugs GXHPC 1 (Primary)
- Indications Liver cirrhosis
- Focus Therapeutic Use
- Sponsors GWOXI Stem Cell Applied Technology
- 15 Apr 2018 Status changed from active, no longer recruiting to completed.
- 19 Dec 2017 Planned End Date changed from 31 Jan 2018 to 27 Mar 2018.
- 04 Jul 2017 Planned End Date changed from 1 Sep 2017 to 31 Jan 2018.